Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study
Nanshan Zhong,1 Jinping Zheng,1 Sang Haak Lee,2 David A Lipson,3 Xin Du,4 Shunquan Wu4 1State Key Laboratory of Respiratory Disease, National Clinical Research Centre of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzh...
Main Authors: | Zhong N, Zheng J, Lee SH, Lipson DA, Du X, Wu S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-once-daily-inhaled-umeclidinium-in-asian-patien-peer-reviewed-article-COPD |
Similar Items
-
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids
by: Edward Kerwin, et al.
Published: (2020-06-01) -
Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy
by: Lal C, et al.
Published: (2016-12-01) -
The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study
by: Requena G, et al.
Published: (2021-03-01) -
Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol
by: Molino A, et al.
Published: (2018-06-01) -
Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review
by: Price D, et al.
Published: (2016-12-01)